Search

Engineering Halomonas TD01 for the low-cost production of polyhydroxyalkanoates

메타 데이터

바이오화학분류
    • 바이오플라스틱
      1. 기타
    • 바이오정밀화학
      1. 기타
    • 화장품용 기능성소재
      1. 기타
    • 의료용 화학소재
      1. 식품첨가제
논문

Engineering Halomonas TD01 for the low-cost production of polyhydroxyalkanoates

학술지

Metabolic engineering

저자명

Tan, D.; Wu, Q.; Chen, J.C.; Chen, G.Q.

초록

The halophile Halomonas TD01 and its derivatives have been successfully developed as a low-cost platform for the unsterile and continuous production of chemicals. Therefore, to increase the genetic engineering stability of this platform, the DNA restriction/methylation system of Halomonas TD01 was partially inhibited. In addition, a stable and conjugative plasmid pSEVA341 with a high-copy number was constructed to contain a LacI<SUP>q</SUP>-P<SUB>trc</SUB> system for the inducible expression of multiple pathway genes. The Halomonas TD01 platform, was further engineered with its 2-methylcitrate synthase and three PHA depolymerases deleted within the chromosome, resulting in the production of the Halomonas TD08 strain. The overexpression of the threonine synthesis pathway and threonine dehydrogenase made the recombinant Halomonas TD08 able to produce poly(3-hydroxybutyrate-co-3-hydroxyvalerate) or PHBV consisting of 4-6mol% 3-hydroxyvalerate or 3HV, from various carbohydrates as the sole carbon source. The overexpression of the cell division inhibitor MinCD during the cell growth stationary phase in Halomonas TD08 elongated its shape to become at least 1.4-fold longer than its original size, resulting in enhanced PHB accumulation from 69wt% to 82wt% in the elongated cells, further promoting gravity-induced cell precipitations that simplify the downstream processing of the biomass. The resulted Halomonas strains contributed to further reducing the PHA production cost.

발행연도

2014

발행기관

Academic Press

ISSN

1096-7176

ISSN

1096-7184

26

페이지

pp.34-47

주제어

PHB; Polyhydroxyalkanoates; Halomonas; Threonine synthesis pathway; Poly(3-hydroxybutyrate-co-3-hydroxyvalerate); Cell division inhibitor; Cell elongation; MinCD

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2014-11-01

Export

About

Search

Trend